Investment funds linked to businessman Nelson Tanure have bought around 26% of medical diagnostics company Alliar, he said on Thursday, complicating a proposed takeover by hospital chain Rede D’Or. Tanure released a...
HealthCare atHOME acquires SuVitas
HealthCare atHOME (HCAH), a health-tech company, on Wednesday said it has acquired SuVitas Holistic Healthcare in a cash and stock deal. Following this, SuVitas will become a 100% subsidiary of the HCAH. Further details...
Illumina closes $7.1 billion deal for cancer test maker Grail amid regulatory hurdles
Illumina Inc has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc, it said on Wednesday amid challenges posed by the U.S. Federal Trade Commission and the European Union antitrust...
Bayer buys biopharma firm Vividion Therapeutics for up to $2 bln
Bayer on Thursday said it acquired U.S.-based biopharmaceuticals company Vividion Therapeutics for up to $2 billion to boost its ability to discover new treatments and lift the value of its drug pipeline. The deal...
Healthium acquires AbGel to strengthen portfolio and expand market presence
Healthium, a global player in medical devices, announced the acquisition of AbGel gelatin sponge business from Mumbai-based Shri SGK Labs, adding to its product portfolio focused on surgical and post-surgical care...
DoJ considering lawsuit to block UnitedHealth bid for Change Healthcare – The Information
The U.S. Department of Justice is weighing a possible lawsuit to block UnitedHealth Group’s nearly $8 billion deal to acquire health care analytics and technology vendor Change Healthcare, the Information reported on...
PerkinElmer to buy antibodies maker BioLegend for about $5.3 billion
Medical diagnostic firm PerkinElmer Inc said on Monday it would buy BioLegend, a privately held maker of reagents and antibodies used in medical research, for about $5.25 billion in a cash-and-stock deal. The deal, the...
PEs look to buy into Integrace, True North may sell 30% stake
A clutch of private equity funds — Singapore’s Temasek Holdings, Kuala Lumpur’s Creador and homegrown Kedaara Capital — are in separate talks to acquire a significant minority stake in Integrace, the Mumbai-based...
BioNTech strengthens cancer therapy expertise with U.S. acquisition
BioNTech said it was acquiring a production site and a research and development platform from a subsidiary of U.S. biotech company Gilead to expand its footprint in North America and in novel cancer treatments. The...
EU antitrust regulators set July 22 deadline for Illumina, Grail deal
EU antitrust regulators will rule by July 22 whether to clear Illumina Inc’s proposed $7.1 billion acquisition of cancer test maker Grail Inc, a European Commission filing showed on Thursday. U.S. life sciences...
UK nod paves way for AstraZeneca-Alexion deal to close next week
AstraZeneca’s $39 billion buyouts of U.S.-based rare diseases business Alexion is expected to close next week as Britain’s competition watchdog cleared the deal on Wednesday. The merger, which will beef up...
Temasek in talks to buy into Covid test kit-maker Molbio
The Singapore government’s investment fund Temasek Holdings is in advanced talks to acquire about 15% stake in Covid-19 test kits maker Molbio Diagnostics for ₹1,500-₹1,800 crore ($250 million), multiple people aware of...
